The relative burden of community-acquired pneumonia hospitalizations in older adults: a retrospective observational study in the United States

被引:79
|
作者
Brown, Joshua D. [1 ]
Harnett, James [2 ]
Chambers, Richard [3 ]
Sato, Reiko [4 ]
机构
[1] Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL 32611 USA
[2] Pfizer Inc, Real World Data & Analyt, Global Hlth & Value, New York, NY USA
[3] Pfizer Inc, Stat Res Data Ctr, Global Prod Dev, Collegeville, PA USA
[4] Pfizer Inc, Global Hlth & Value, Outcomes & Evidence, Collegeville, PA USA
来源
BMC GERIATRICS | 2018年 / 18卷
关键词
Community-acquired pneumonia; Burden of illness; Geriatrics; Vaccinations; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; AGED GREATER-THAN-OR-EQUAL-TO-65 YEARS; IMMUNIZATION PRACTICES ACIP; CONJUGATE VACCINE; ADVISORY-COMMITTEE; COST-EFFECTIVENESS; MEDICARE BENEFICIARIES; INFLUENZA VACCINATION; ADMINISTRATIVE DATA; POPULATION;
D O I
10.1186/s12877-018-0787-2
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: The risk of community-acquired pneumonia (CAP) increases with age and significantly impacts morbidity and mortality in the elderly population. The burden of illness and cost of preventing CAP has not been compared to other serious diseases. Methods: This retrospective analysis used claims data from 2014 to 2015 and compared hospitalizations for CAP, myocardial infarction (MI), stroke, and osteoporotic fractures (OF) in adults aged >= 65 years enrolled in a Medicare Advantage insurance plan. Individuals who had not already been hospitalized for one of these conditions and did not have evidence of long-term care were included in the study. Hospitalizations for each condition were described by length of stay, readmissions, mortality, and total costs. Preventive measures included vaccinations for CAP and medications for MI, stroke, and OF. Results: A total of 1,949,352 individuals were included in the cohort. In 2015, the rate of CAP-related hospitalizations was the highest at 846.7 per 100,000 person-years compared to 405 for MI, 278.9 for stroke, and 343.9 for OF. Vaccination costs for CAP were $40.2 million including $14.1 million for pneumococcal and $26.1 million for influenza vaccines. The cost of preventive medications for MI and stroke reached over $661 million and OF totaled $169 million. Conclusions: Although CAP has a higher burden of hospitalization and total costs than MI, stroke, and OF in the elderly population, prevention efforts were disproportionately smaller for CAP. Prioritization of CAP prevention is needed to substantially reduce the burden of CAP.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Management of community-acquired pneumonia in primary care: an observational study
    Launders, Naomi
    Ryan, Dermot
    Winchester, Chris
    Skinner, Derek
    Konduru, Priyanka
    Price, David
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [42] A clinical pathway for community-acquired pneumonia: an observational cohort study
    Frei, Christopher R.
    Bell, Allison M.
    Traugott, Kristi A.
    Jaso, Terry C.
    Daniels, Kelly R.
    Mortensen, Eric M.
    Restrepo, Marcos I.
    Oramasionwu, Christine U.
    Ruiz, Andres D.
    Mylchreest, William R.
    Sikirica, Vanja
    Raut, Monika R.
    Fisher, Alan
    Schein, Jeff R.
    BMC INFECTIOUS DISEASES, 2011, 11
  • [43] Environmental Risk Factors for Community-Acquired Pneumonia Hospitalization in Older Adults
    Loeb, Mark
    Neupane, Binod
    Walter, Stephen D.
    Hanning, Rhona
    Carusone, Soo Chan
    Lewis, David
    Krueger, Paul
    Simor, Andrew E.
    Nicolle, Lindsay
    Marrie, Thomas J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 (06) : 1036 - 1040
  • [44] Severe community-acquired pneumonia compared to severe community-acquired Acinetobacter baumannii pneumonia in Reunion Island: A retrospective study
    Rotini, Giacomo
    de Mangou, Axel
    Combe, Agathe
    Renou, Amelie
    Combe, Chloe
    Cally, Radj
    Lagrange-Xelot, Marie
    Allou, Nicolas
    Miltgen, Guillaume
    Vidal, Charles
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2025, 30 (01) : 43 - 50
  • [45] Diagnosis and Therapy of Community-Acquired Pneumonia in the Emergency Department: A Retrospective Observational Study and Medical Audit
    Luthi-Corridori, Giorgia
    Roth, Andrea I.
    Boesing, Maria
    Jaun, Fabienne
    Tarr, Philip E.
    Leuppi-Taegtmeyer, Anne B.
    Leuppi, Jorg D.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
  • [46] Anticholinergic Medication Use and Risk of Community-acquired Pneumonia in Older Adults
    Paul, Kathleen J.
    Walker, Rod L.
    Dublin, Sascha
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 334 - 334
  • [47] Epidemiology and mortality predictors for severe childhood community-acquired pneumonia in ICUs: A retrospective observational study
    Cao, Lu
    Ji, Zhaohua
    Zhang, Peng
    Wang, Jingwen
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [48] The United States guidelines for the management of community-acquired pneumonia and their relevance to Australasia
    Waterer, G. W.
    Grayson, M. L.
    INTERNAL MEDICINE JOURNAL, 2007, 37 (12) : 789 - 791
  • [49] Definitive and Indeterminate Pseudomonas aeruginosa Infection in Adults with Community-acquired Pneumonia A Prospective Observational Study
    Sando, Eiichiro
    Suzuki, Motoi
    Ishida, Masayuki
    Yaegashi, Makito
    Aoshima, Masahiro
    Ariyoshi, Koya
    Morimoto, Konosuke
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (09) : 1475 - 1481
  • [50] Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review
    Torres, Antoni
    Cilloniz, Catia
    Blasi, Francesco
    Chalmers, James D.
    Gaillat, Jacques
    Dartois, Nathalie
    Schmitt, Heinz-Josef
    Welte, Tobias
    RESPIRATORY MEDICINE, 2018, 137 : 6 - 13